MedTrace Logo

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

NCT01366170 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2016-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. it may also help doctors predict how patients will respond to treatment.

PURPOSE: This research trial studies biomarker expression in tissue samples from young patients with anaplastic large cell lymphoma.

Conditions

Interventions

GENETIC

microarray analysis

GENETIC

protein expression analysis

GENETIC

western blotting

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Megan S. Lim, MD, PhD · C.S. Mott Children's Hospital at University of Michigan Medical Center

Eligibility

Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01366170 on ClinicalTrials.gov